Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential violations of federal and state laws by officers and directors of Elanco Animal Health Incorporated (NYSE: ELAN).

As a long-term shareholder, you may have legal standing to hold the company’s officers and directors accountable for alleged misconduct:

Recently a class action lawsuit was filed against the company alleging that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Zenrelia was less safe than the Company had led investors to believe; (ii) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.